Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H12FNO3 |
| Molecular Weight | 212.2081 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@H](CC1=CC=C(OC[18F])C=C1)C(O)=O
InChI
InChIKey=GEBHVOHKNWLITQ-DEVVULMSSA-N
InChI=1S/C10H12FNO3/c11-6-15-8-3-1-7(2-4-8)5-9(12)10(13)14/h1-4,9H,5-6,12H2,(H,13,14)/t9-/m1/s1/i11-1
BAY-86-9596 (D-18F-FMT, or O-18F-fluoromethyl-D-tyrosine) was developed as an agent not only for tumor detection but also for monitoring early-phase response to radiation therapy by positron emission tomography (PET). This drug participated in clinical trials for patients with inflammation and solid tumors, but further information about trials is not available.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB15296
Created by
admin on Mon Mar 31 23:07:36 GMT 2025 , Edited by admin on Mon Mar 31 23:07:36 GMT 2025
|
PRIMARY | |||
|
870452-26-9
Created by
admin on Mon Mar 31 23:07:36 GMT 2025 , Edited by admin on Mon Mar 31 23:07:36 GMT 2025
|
PRIMARY | |||
|
11579379
Created by
admin on Mon Mar 31 23:07:36 GMT 2025 , Edited by admin on Mon Mar 31 23:07:36 GMT 2025
|
PRIMARY | |||
|
300000041416
Created by
admin on Mon Mar 31 23:07:36 GMT 2025 , Edited by admin on Mon Mar 31 23:07:36 GMT 2025
|
PRIMARY | |||
|
58HVN5SR99
Created by
admin on Mon Mar 31 23:07:36 GMT 2025 , Edited by admin on Mon Mar 31 23:07:36 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
